PRF1, which served as a definite marker of the killing ability of immune cells, is associated with better survival in multiple cancers, such as bladder cancer, melanoma, and head and neck squamous cell carcinoma (48, 49). This evidence concerns the gene PRF1 and head and neck squamous cell carcinoma.